From McGill Universitythe.
University of Calgaryand the.
Plast Reconstr Surg. 2023 Feb 1;151(2):278-288. doi: 10.1097/PRS.0000000000009830. Epub 2022 Nov 8.
Decision aids are useful adjuncts to clinical consultations for women considering breast reconstruction. This study compared the impact of two online decision aids, the Breast RECONstruction Decision Aid (BRECONDA) and the Alberta Health Services (AHS) decision aid, on decisional conflict, decisional satisfaction, and decisional regret.
This randomized controlled trial included 60 women considering whether or not to undergo breast reconstruction. Two online decision aids, the AHS and the BRECONDA, were compared using randomized two-arm equal allocation. Participants responded to questionnaires at baseline, after the first and second consultations, and at 6 weeks and 6 months after deciding to, or not to, undergo reconstruction. Change in decisional conflict scores was compared between the BRECONDA and the AHS decision aid. Secondary outcomes included decisional regret and decisional satisfaction.
Both groups were similar in demographic, clinical, and behavioral characteristics. Women spent more time consulting the BRECONDA in comparison to women using the AHS decision aid (56.7 ± 53.8 minutes versus 28.4 ± 27.2 minutes; P < 0.05). Decisional conflict decreased (P < 0.05), and decisional satisfaction improved over time in both groups (P < 0.05). However, there were no differences based on the type of decision aid used (P > 0.05). Both decision aids had a similar reduction in decisional regret (P > 0.05).
Decision aids decrease decisional conflict and improve decisional satisfaction among women considering breast reconstruction. Physicians should therefore offer patients access to decision aids as an adjunct to breast reconstruction consultations to help patients make an informed decision.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.
决策辅助工具对于考虑乳房重建的女性来说是临床咨询的有用辅助手段。本研究比较了两种在线决策辅助工具,即乳房重建决策辅助工具(BRECONDA)和艾伯塔省卫生服务(AHS)决策辅助工具,对决策冲突、决策满意度和决策后悔的影响。
本随机对照试验纳入了 60 名考虑是否进行乳房重建的女性。使用随机两臂均等分配法比较了两种在线决策辅助工具,即 AHS 和 BRECONDA。参与者在基线、第一次和第二次咨询后、决定进行或不进行重建后的 6 周和 6 个月时回答问卷。比较了 BRECONDA 和 AHS 决策辅助工具之间决策冲突评分的变化。次要结局包括决策后悔和决策满意度。
两组在人口统计学、临床和行为特征方面相似。与使用 AHS 决策辅助工具的女性相比,女性使用 BRECONDA 花费更多的时间咨询(56.7 ± 53.8 分钟与 28.4 ± 27.2 分钟;P < 0.05)。两组的决策冲突均减少(P < 0.05),决策满意度随时间改善(P < 0.05)。然而,使用的决策辅助工具类型没有差异(P > 0.05)。两种决策辅助工具均使决策后悔减少(P > 0.05)。
决策辅助工具可减少考虑乳房重建的女性的决策冲突并提高决策满意度。因此,医生应向患者提供决策辅助工具,作为乳房重建咨询的辅助手段,以帮助患者做出明智的决策。
临床问题/证据水平:治疗,I 级。